Discipline Pharmacological and Pharmaceutical Sciences
Subdiscipline Drug Discovery in Cancer Epigenetics
Event Type Conference
Delegate Fee 250euro-500euro
Conference Aims and Objectives
The ICDDCE 2020: 22nd International Conference on Drug Discovery in Cancer Epigenetics aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Drug Discovery in Cancer Epigenetics. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Drug Discovery in Cancer Epigenetics.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Drug Discovery in Cancer Epigenetics are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.